Replies to post #162267 on NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Don’t worry about "Meifud" and its figures. He's not as good at mathematics.

<snip>

“19% of control patients received DCVax-L at a later time after their disease progressed”???

WE ALL KNOW BETTER!

Well, 19% of patients in the trial were control patients who received DCVax-L. At least going by the numbers LL presented.

One might well assert his English was off. But his math was obviously correct.